As the pioneering data to demonstrate PMBPs' efficacy to trigger apoptosis by activating the mitochondria-associated apoptotic pathway and to inhibit cell migration and invasion via MMP-9 down-regulation, PMBPs could be developed as a novel effective anti-tumor agent for ovarian cancer treatment. This evidence concerns the gene MMP9 and ovarian cancer.